Results

Total Results: 1,391 records

Showing results for "risk".

1. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction-2002
   May 06, 2002 - The relative risk reduction was similar across all age groups and all risk levels. … was concentrated in women ages 50 and older; the relative risks for women younger than age 50 were smaller … for recruitment into the study. 40 Given a constant relative risk reduction across breast cancer risk … and the relative risk by which the baseline risk is multiplied for tamoxifen users. … ‡HR, hazard ratio, the estimate of relative risk at a given time.

2. Archived: Coronary Heart Disease: Screening Using Non-Traditional Risk Factors | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/recommendation/coronary-heart-disease-screening-using-non-traditional-risk-factors-2009
   October 15, 2009 - significant relative risks that ranged from 1.36 to 1.90. … factors in asymptomatic persons (1300 to 16 000 men and women who showed a relative risk of 1.19 to … In summary, although the 8 included studies consistently reported statistically significant relative … risks for coronary events with increasing CAC scores, no study uniformly met all 3 of the following conditions … risk variables (including diabetes), the summary estimate of relative risk for incident CHD was 1.58

3. Archived: Evidence Summary: NSAIDs: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
   March 15, 2007 - Confounders Addressed in Adjusted Relative Risks among the Included Case-Control Studies: Use of Nonaspirin … Confounders Addressed in Adjusted Relative Risks among the Included Case-Control Studies: Duration of … We chose relative risk as the effect measure. … Confounders Addressed in Adjusted Relative Risks among the Included Case-Control Studies: Use of Nonaspirin … Confounders Addressed in Adjusted Relative Risks among the Included Case-Control Studies: Duration of

4. Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/EppFbhnDEX5UtYWrTkLEhT
   March 01, 2007 - We chose relative risk as the effect measure. … We directly abstracted point esti- mates of the adjusted relative risks and their 95% CIs from the reports … NSAIDs [54]; 1.43 (0.99–2.07) for rofecoxib vs. celecoxib [58] * Data reported are relative risks (95% … Confounders Addressed in Adjusted Relative Risks among the Included Case–Control Studies: Use of Nonaspirin … Confounders Addressed in Adjusted Relative Risks among the Included Case–Control Studies: Duration of

5. Using Nontraditional Risk Factors in Coronary Heart Disease Risk Assessment: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/gXnmnkofo8FxoLnCmXJDjb
   October 01, 2009 - sig- nificant relative risks that ranged from 1.36 to 1.90. … fac- tors in asymptomatic persons (1300 to 16 000 men and women who showed a relative risk of 1.19 … In summary, although the 8 included studies consis- tently reported statistically significant relative … risks for cor- onary events with increasing CAC scores, no study uni- formly met all 3 of the following … of relative risk for incident CHD was 1.58 (CI, 1.37 to 1.83) for an hs-CRP level greater than 3.0 mg

6. Modeling Study: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-modeling-study/aspirin-to-prevent-cardiovascular-disease-preventive-medication
   April 26, 2022 - In all scenarios, non-CRC benefits and harms were assumed to take effect immediately, and relative risks … estimate was lower and had a narrower confidence interval compared with the corresponding finding in 2016 (relative … for CRC incidence and affects fatal major gastrointestinal bleeding risks. … constant over time, but lifetime net benefits of aspirin would be higher if these relative risks decreased … CVD Parameter Relative

7. Chemo and Couns/2nd instal (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/-hnLT26c2NHs6thK9yznPF
   July 01, 2002 - The relative risk reduction was similar across all age groups and all risk levels. … was concentrated in women aged 50 and older; the relative risks for women younger than age 50 were smaller … Considerations of Risk of Developing Breast Cancer The relative risk reduction for estrogen receptor … for recruitment into the study.40 Given a constant relative risk reduction across breast cancer risk … and the relative risk by which the baseline risk is multiplied for tamoxifen users.

8. Archived: Evidence Summary: Hepatitis B Virus Infection: Screening, 2014 | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary29/hepatitis-b-virus-infection-screening-nonpregnant-adolescents-adults-may-2014
   May 27, 2014 - For antiviral therapy and vaccination, we conducted meta-analyses to calculate relative risks using the … For antiviral therapy and vaccination, we conducted meta-analyses to calculate relative risks using the … There are 2 studies comparing adefovir and placebo, with a pooled relative risk of 2.02 and 95% CI of … Two studies had no incidence of mortality in either group, resulting in relative risks that were not … In the third study, the relative risk was 1.48 with a 95% CI of 0.48 to 4.53.

9. Archived: Evidence Summary: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 2002 | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/aspirin-use-prevent-cardiovascular-disease-colorectal-cancer-preventive-medication-2002
   January 15, 2002 - In PHS, aspirin reduced the relative risk for myocardial infarction for patients aged 70 to 84 years … Relative risks were 0.75 for patients aged 50 to 59 years and 0.61 for patients aged 60 to 64 years. … In PHS, patients who were taking aspirin and had SBP greater than 150 mm Hg had a relative risk of 0.65 … for myocardial infarction, compared with relative risks of 0.55 for those with SBP between 130 and 149 … The summary relative risk for hemorrhagic stroke with aspirin use was 1.84 (95 percent CI, 1.24 to 2.74

10. Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/xUc_vXf7323faUQY7SePhT
    January 01, 2002 - Age In PHS, aspirin reduced the relative risk for myocardial infarction for patients aged 70 to 84 years … Relative risks were 0.75 for patients aged 50 to 59 years and 0.61 for patients aged 60 to 64 years. … In PHS, patients who were taking aspirin and had SBP greater than 150 mm Hg had a relative risk of 0.65 … for myocardial infarction, compared with relative risks of 0.55 for those with SBP between 130 and … The summary relative risk for hemorrhagic stroke with aspirin use was 1.84 (95% CI, 1.24 to 2.74).

11. Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/3HxQuXnyqHpUKNqjB7hWBw
    September 01, 2005 - risks for breast and ovarian cancer in moderate- and high-risk groups. … All chemoprevention trials reported relative risk (RR) estimates, and the logarithm of the RR (logRR) … Combining all trials in a meta-analysis resulted in a relative risk for total breast cancer of 0.62 ( … The relative risk (0.39 [CI, 0.20 to 0.79]) was further reduced for estrogen receptor–positive breast … Relative risks for breast cancer in chemoprevention trials.

12. Tagauj5Qoarfv3M8Fapbon (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/TAgAUJ5QoaRfV3M8fApBoN
    June 03, 2019 - below 1 after 16 or more years of follow-up (relative risk, 0.79). … The relative risks by year of observation (including trial plus follow-up time) are shown in the Figure … Both of these trials reported relative risk re- ductions among women 65 to 74 years of age (relative … (50), 1997 No 5 Swedish trials Weighted relative risks 12.8 0.77 (0.59–1.01) Nyström et al. (32), … Relative risk was calculated as exp(�).

13. Archived: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction-2013
    September 15, 2013 - that treatment with tamoxifen or raloxifene can significantly reduce the relative risk (RR) for invasive … Breast Cancer Prevention Trial; IBC = invasive breast cancer; WHI = Women's Health Initiative; RR = relative … Breast Cancer Prevention Trial; IBC = invasive breast cancer; WHI = Women's Health Initiative; RR = relative … Breast Cancer Prevention Trial; IBC = invasive breast cancer; WHI = Women's Health Initiative; RR = relative … Breast Cancer Prevention Trial; IBC = invasive breast cancer; WHI = Women's Health Initiative; RR = relative

14. Screening for Ovarian Cancer: Review (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/cTa7Hs56-yj4kCr7yXLdRm
    July 01, 1994 - Using the relative risks reported by Kerlikowske and colleagues (16), we can estimate that a family … Calculated from relative risk estimates and ovarian cancer incidence data from the SEER (Surveillance … associated with contraceptive pill use; both found similar relative risks of approximately 0.65 associated … ; both studies found a relative risk of approximately 0.5 after 5 years of use. 3.11 Parity has also … 50% (that is, a relative risk of 0.5) for any pregnancy, with decreasing risk associated with an increasing

15. Archived: Evidence Summary: Bleeding Risks With Aspirin Use: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-bleeding-risks-with-aspirin-use/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    April 11, 2016 - outcome, we calculated a range of expected event rates after aspirin intervention using the pooled relative … events will vary depending on individual baseline bleeding risks. … why persons with these risks have been excluded from trials. … Level † Baseline Risk for Outcome, events per 1000 person-years Relative Risk (95% CI) Events … ¶ Using cohort baseline risk and trial relative risks to estimate events caused or prevented.

16. Archived: Evidence Summary: Breast Cancer: Screening, 2002 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-screening-2002
    September 03, 2002 - Data Synthesis: For studies of fair quality or better, the summary relative risk was 0.84 (95% CrI, … follow-up (relative risk, 0.79). … The relative risks by year of observation (including trial plus follow-up time) are shown in the Figure … Both of these trials reported relative risk reductions among women 65 to 74 years of age (relative risk … Relative risk was calculated as exp(β).

17. Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/j69Hq5ALvzg74e-ngkzSep
    April 01, 2016 - outcome, we calcu- lated a range of expected event rates after aspirin in- tervention using the pooled relative … Baseline Estimates of Major Bleeding Risks (Trial vs. … Risk for Outcome, events per 1000 person-years Relative Risk (95% CI) Events Caused per 1000 Person-Years … as reported by included cohort studies. ¶ Using cohort baseline risk and trial relative risks to estimate … why persons with these risks have been excluded from trials.

18. Clinical Summary: Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/uPbfDukSXmFDWq8FDwTgKj
    Clinical Summary: Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors … Clinical Summary: Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors Population … Grade: I (insufficient evidence) Risk Assessment Several traditional risk factors are associated … Risk factors can be combined in many w ays to classify a person's risk for a CVD event. … CVD risk assessment in the United States has been generally based on the Framingham Risk Score and the

19. Using Aspirin for the Primary Prevention of Cardiovascular Disease (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/4fdC2JLwP_um_yZe4WZRaa
    April 01, 2009 - prevention studies of aspirin have found the following: Clinician Fact Sheet Aspirin use in women y 17% relative … relative risk reduction for MI y No effect on stroke or all-cause mortality y Talk With Your … Harms from aspirin include the risks of serious upper GI bleeding and hemorrhagic stroke. … this risk in women. … For these individuals, the benefits and risks of using aspirin are closely balanced.

20. Archived: Evidence Summary: Breast and Ovarian Cancer: BRCA Genetic Testing, September 2005 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-and-ovarian-cancer-brca-testing-screening-2005
    September 15, 2005 - risks for breast and ovarian cancer in moderate- and high-risk groups. … All chemoprevention trials reported relative risk (RR) estimates, and the logarithm of the RR (logRR) … Sampling Distribution for Relative Risk When developing the outcomes table, the estimates of relative … Risk (95% CI) Type Treat- ment Group,  n Placebo Group, n Relative Risk … Relative Risks for Breast Cancer in Chemoprevention Trials